or Try an Advanced Search...

    Stage Biopharmaceutical Stocks List

    Symbol Grade Name % Change
    PXMD F PaxMedica, Inc. -46.24
    OCGN B Ocugen, Inc. -5.04
    HCWB F HCW Biologics Inc. -4.13
    SGMO F Sangamo BioSciences, Inc. -4.01
    PIRS F Pieris Pharmaceuticals, Inc. -3.77
    CTNM D Contineum Therapeutics, Inc. -3.56
    NERV F Minerva Neurosciences, Inc -2.08
    ACXP F Acurx Pharmaceuticals, Inc. -1.85
    FWBI F First Wave BioPharma, Inc. -1.76
    MIRA F MIRA Pharmaceuticals, Inc. -1.39
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - General
    Related Stock Lists: Medicine Biotechnology Life Sciences Neuroscience Acute Myeloid Leukemia Age Related Diseases Ajulemic Acid Alopecia Areata Antibiotics Antidepressants Antiemetics Appetite Stimulants Asthma Autism Spectrum Disorder Bacterial Infections Biopharmaceutical Blastoma Blindness Blood Plasma Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Stage Biopharmaceutical stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 0.78
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.48
    BTEC C Principal Healthcare Innovators Index ETF 0.05
    IWC C iShares Microcap ETF 0.03
    VHT C Vanguard Health Care ETF 0.01
    View all Stage Biopharmaceutical ETFs...
    Compare ETFs
    Compare BTEC to IWC Compare GERM to BTEC Compare GERM to IWC

        Stage Biopharmaceutical Stocks Recent News

        Date Stock Title
        May 2 SGMO Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
        May 2 OCGN Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
        May 2 ACXP Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
        May 1 NERV Minerva Neurosciences GAAP EPS of -$1.13
        May 1 NERV Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
        Apr 29 OCGN Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
        Apr 29 FWBI Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
        Apr 29 OCGN Can Ocugen Stock Keep Churning Higher?
        Apr 29 OCGN Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024
        Apr 26 OCGN Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
        Apr 26 OCGN UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
        Apr 26 PXMD PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
        Apr 26 OCGN Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
        Related Industries: Biotechnology Drug Manufacturers - General
        Related Stock Lists: Medicine Biotechnology Life Sciences Neuroscience Acute Myeloid Leukemia Age Related Diseases Ajulemic Acid Alopecia Areata Antibiotics Antidepressants Antiemetics Appetite Stimulants Asthma Autism Spectrum Disorder Bacterial Infections Biopharmaceutical Blastoma Blindness Blood Plasma Cancer
        Stage Biopharmaceutical

        Browse All Tags